S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
How major US stock indexes fared Thursday, 3/28/2024
MillerKnoll, Chemours fall; Verint Systems, RH rise, Thursday, 3/28/2024
Mark Zuckerberg Says This CEO Is the 'Taylor Swift of Tech'
NASDAQ:CRON

Cronos Group (CRON) Stock Price, News & Analysis

$2.61
-0.09 (-3.33%)
(As of 03/28/2024 ET)
Today's Range
$2.61
$2.77
50-Day Range
$1.93
$2.70
52-Week Range
$1.64
$2.77
Volume
4.98 million shs
Average Volume
3.20 million shs
Market Capitalization
$995.19 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.67

Cronos Group MarketRank™ Stock Analysis

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
2.2% Upside
$2.67 Price Target
Short Interest
Healthy
3.24% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.69mentions of Cronos Group in the last 14 days
Based on 18 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.01) to $0.03 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.69 out of 5 stars

Medical Sector

869th out of 939 stocks

Medicinals & Botanicals Industry

9th out of 11 stocks

CRON stock logo

About Cronos Group Stock (NASDAQ:CRON)

Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones brand in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

CRON Stock Price History

CRON Stock News Headlines

The 3 Best Cannabis Stocks to Buy in Q2 2024
The 3 Best Meme Stocks to Buy in Q2 2024
Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
Cronos Group (NASDAQ:CRON) Hits New 12-Month High at $2.68
Cronos Group (NASDAQ:CRON) Hits New 12-Month High at $2.68
A lot of people are making this costly mistake
You may have heard the saying “options are risky” … And, they can be. But only if you use them the way a lot of folks do. A lot of people think of BUYING speculative options when they talk about options. And BUYING low probability, speculative options is definitely risky… It’s how some folks leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time.
Cronos Launches Lord Jones® Chocolate Fusions
Cronos Group (NASDAQ:CRON) Stock Price Up 5%
Altria: Still Undervalued, Buy On Strength
See More Headlines
Receive CRON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/29/2024
Today
3/29/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medicinals & botanicals
Sub-Industry
N/A
Current Symbol
NASDAQ:CRON
Fax
N/A
Employees
356
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$2.67
High Stock Price Target
$3.00
Low Stock Price Target
$2.00
Potential Upside/Downside
+2.2%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

Net Income
$-73,960,000.00
Pretax Margin
-84.44%

Debt

Sales & Book Value

Annual Sales
$87.24 million
Book Value
$2.87 per share

Miscellaneous

Free Float
373,826,000
Market Cap
$995.19 million
Optionable
Optionable
Beta
1.13
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Michael Ryan Gorenstein J.D.Mr. Michael Ryan Gorenstein J.D. (Age 37)
    President, CEO & Chairman
    Comp: $3.94M
  • Mr. James Holm (Age 41)
    Chief Financial Officer
    Comp: $314.31k
  • Mr. Jeffrey David Jacobson (Age 38)
    Chief Growth Officer
    Comp: $730.12k
  • Ms. Anna Shlimak (Age 38)
    Senior Vice President of Corporate Affairs & Strategy
    Comp: $530.5k
  • Mr. James Andrew McGinness III (Age 45)
    VP, Controller & Principal Accounting Officer
  • Mr. Shayne J. Laidlaw
    Director of Investor Relations & Strategy
  • Mr. Terry Gregory-Joseph Doucet (Age 34)
    General Counsel & Corporate Secretary
  • Ms. Shannon Buggy (Age 54)
    Senior VP & Global Head of People
    Comp: $438.81k
  • Mr. Arye Weigensberg (Age 41)
    Senior VP & Head of Research and Development

CRON Stock Analysis - Frequently Asked Questions

Should I buy or sell Cronos Group stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last year. There are currently 1 sell rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CRON shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CRON, but not buy additional shares or sell existing shares.
View CRON analyst ratings
or view top-rated stocks.

What is Cronos Group's stock price target for 2024?

3 brokerages have issued 1 year target prices for Cronos Group's shares. Their CRON share price targets range from $2.00 to $3.00. On average, they predict the company's stock price to reach $2.67 in the next year. This suggests a possible upside of 2.2% from the stock's current price.
View analysts price targets for CRON
or view top-rated stocks among Wall Street analysts.

How have CRON shares performed in 2024?

Cronos Group's stock was trading at $2.09 at the beginning of the year. Since then, CRON stock has increased by 24.9% and is now trading at $2.61.
View the best growth stocks for 2024 here
.

When is Cronos Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our CRON earnings forecast
.

How were Cronos Group's earnings last quarter?

Cronos Group Inc. (NASDAQ:CRON) issued its earnings results on Thursday, February, 29th. The company reported ($0.05) earnings per share (EPS) for the quarter. The business earned $23.92 million during the quarter, compared to analyst estimates of $25.15 million. Cronos Group had a negative trailing twelve-month return on equity of 3.99% and a negative net margin of 84.15%.

What other stocks do shareholders of Cronos Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Tilray (TLRY), NVIDIA (NVDA), Advanced Micro Devices (AMD), Dollar Tree (DLTR), Micron Technology (MU), Alibaba Group (BABA) and Organigram (OGI).

Who are Cronos Group's major shareholders?

Cronos Group's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (1.86%), Vanguard Group Inc. (1.86%), Dimensional Fund Advisors LP (0.53%), Intact Investment Management Inc. (0.23%), Mirae Asset Global Investments Co. Ltd. (0.18%) and AdvisorShares Investments LLC (0.13%).
View institutional ownership trends
.

How do I buy shares of Cronos Group?

Shares of CRON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CRON) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners